There’s a lot of talk in the mainstream financial media about Big Tech.
Rightfully so, when the Magnificent 7 stocks dictate how the market performs more than any one group of stocks. When a group of seven stocks garners that much attention, it usually means other sectors and groups are going unnoticed by Wall Street analysts.
I remembered running scans for stocks that were trending higher in momentum and outpacing the benchmark S&P 500, and found that many biotech and biopharma stocks made the cut.
This post appeared first on Money & Markets.